Risk of acute pancreatitis with incretin-based therapy: a systematic review and updated meta-analysis of cardiovascular outcomes trials. Issue 4 (2nd April 2020)
- Record Type:
- Journal Article
- Title:
- Risk of acute pancreatitis with incretin-based therapy: a systematic review and updated meta-analysis of cardiovascular outcomes trials. Issue 4 (2nd April 2020)
- Main Title:
- Risk of acute pancreatitis with incretin-based therapy: a systematic review and updated meta-analysis of cardiovascular outcomes trials
- Authors:
- Singh, Awadhesh Kumar
Gangopadhyay, Kalyan Kumar
Singh, Ritu - Abstract:
- ABSTRACT: Background: The link of acute pancreatitis (AP) with Incretin based therapies (IBTs) in type 2 diabetes has existed since United States Food and Drug Administration alert in 2010. This issue still remains unresolved due to conflicting results among studies. Research design and methods: We performed a systematic search of the PubMed, Embase, and Cochrane Library databases until 31 July 2019, and retrieved all cardiovascular outcome trials (CVOTs) of IBTs conducted for ≥12 months that reported the pre-specified and or pre-adjudicated pancreatitis outcomes. Subsequently, we conducted a meta-analysis to study the risk of AP observed with IBT in CVOTs. Results: A meta-analysis of seven CVOTs of GLP-1 receptor agonists (GLP-1RAs) compared with placebo (N = 55, 932) found no significant increase in AP (odds ratio [OR], 1.05; 95% confidence interval [CI], 0.77–1.42; p = 0.77). In contrast, meta-analysis of five CVOTs comparing DPP-4 inhibitors with placebo (N = 47, 714) and six CVOTs comparing DPP-4 inhibitors with placebo or active comparator (N = 53, 747), found a significant increase (OR, 1.81; 95% CI, 1.21–2.70; p = 0.04 and OR, 1.54; 95% CI, 1.08–2.18; p = 0.02, respectively) in AP without any significant heterogeneity. Conclusions: This meta-analysis revealed a significant association between pancreatitis and DPP-4 inhibitors; however, no such association was observed for GLP-1RAs.
- Is Part Of:
- Expert review of clinical pharmacology. Volume 13:Issue 4(2020)
- Journal:
- Expert review of clinical pharmacology
- Issue:
- Volume 13:Issue 4(2020)
- Issue Display:
- Volume 13, Issue 4 (2020)
- Year:
- 2020
- Volume:
- 13
- Issue:
- 4
- Issue Sort Value:
- 2020-0013-0004-0000
- Page Start:
- 461
- Page End:
- 468
- Publication Date:
- 2020-04-02
- Subjects:
- Type 2 diabetes -- acute pancreatitis -- DPP-4 inhibitors -- GLP-1 receptor agonists -- cardiovascular outcome trials
Clinical pharmacology -- Periodicals
615.105 - Journal URLs:
- http://informahealthcare.com/toc/erj/current ↗
http://www.future-drugs.com/loi/ecp ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/17512433.2020.1736041 ↗
- Languages:
- English
- ISSNs:
- 1751-2433
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9830.068000
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 13798.xml